{"file_path": "/Users/sz904/Desktop/11711/LTI_Neural_Navigator/data/2024-02-26/chunk_paper_txt/Rita_Singh_A_Gene-Based_Algorithm_for_Identifying_Factors_That_May_Affect_a_Speaker\u2019s_Voice_chunk_13.txt", "num_qa_pairs": 10, "qa_list": [{"question": " What is the syndrome associated with Chromosome 12 deletions at 12q14.3?,answer: Silver-Russell syndrome 5; SRS5", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What are some of the genes associated with the Chromosome 13 deletions at 13q14?,answer: RB1, FOXO1, GTF2F2, KBTBD7, SLC25A1, HTR2A, TNFSF11, LPAR6, CYSLTR2, DGKH, WDFY2, ITM2B, DLEU2, DLEU1, AKAP11", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What is another name for the syndrome associated with Chromosome 13 deletions at 13q33\u2013q34?,answer: Chromosome 13q33\u2013q34 deletion syndrome", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What are some of the implicated genes associated with Chromosome 14 deletions at 14q11\u2013q22?,answer: FLI1, HMGA2, POMP, RB1, EDNRB, PAX9, SUPT16H, CHD8, RALGAPA1", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What syndrome is associated with Chromosome 14 deletions at 14q22.1\u2013q23.1?,answer: Frias syndrome; Chromosome 14q22 deletion syndrome; growth deficiency, facial anomalies, and brachydactyly", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What is the syndrome associated with Chromosome 14 deletions at 14q32.2?,answer: Kagami-Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What syndrome is linked to Chromosome 15 deletions at 15q11.2?,answer: Burnside-Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What are some of the genes associated with Chromosome 15 deletions at 15q11\u2013q13?,answer: HERC2, TJP1, RYR3, GABRA5, CYFIP1, UBE3A, GABRB3, CHRNA7, GABRG3, TUBGCP5, MTMR10, HMGN2P, FMN1", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What syndrome is associated with Chromosome 15 deletions at 15q13.3?,answer: Chromosome 15q13.3 microdeletion syndrome", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}, {"question": " What syndrome is linked to Chromosome 15 deletions at 15q24?,answer: Witteveen-Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome", "ref_chunk": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}], "doc_text": "GRAMD1B1 EI241 Chromosome 12 deletions 12q14.3 OMIM: 618908 Names: Silver\u2013Russell syndrome 5; SRS5 {VN2}: IRAK318 WIF115 MIR650215 GNS15 MSRB312 LEMD310 GRIP19 HMGA27 CAND17 Chromosome 13 deletions 13q12.3 OMIM: 601952 Names: Keratosis linearis with ichthyosis congenita and sclerosing keratoderma syndrome; KLICK syndrome {VN2}: HMGB143 FLT136 ALOX5AP13 SLC7A111 HSPH111 B3GLCT5 13q14 OMIM: 613884; Cytogenetic location: 13q14 Genomic coordinates (GRCh38): 13:50,300,000\u2013 54,700,000 Names: Chromosome 13q14 deletion syndrome {VN2}: RB194 FOXO191 GTF2F251 KBTBD750 SLC25A1524 HTR2A23 TNFSF1118 LPAR616 CYSLTR215 DGKH14 (36 more . . .) WDFY21 ITM2B1 DLEU21 DLEU11 AKAP111 13q22.3 OMIM: 277580; Names: Waardenburg syndrome, Type 4A; WS4A; Waardenburg syndrome with Hirschsprung disease, Type 4A; Waardenburg\u2013Shah syndrome; Shah\u2013Waardenburg syndrome; WS4 {VN2}: EDNRB26 FBXL310 MYCBP21 (SOX1, ARHGEF7) \u2020\u2021 13q33\u2013q34 OMIM: 619148; Cytogenetic location: 13q33\u2013q34 Genomic coordinates (GRCh38): 13:106,400,000\u2013 114,364,328 Names: Chromosome 13q33\u2013q34 deletion syndrome {VN2}: IRS2108 RASA352 TFDP148 F746 F1045 CDC1637 COL4A136 COL4A233 ARHGEF731 ATP4B27 (20 more . . .) ING11 Chromosome 14 deletions 14q11\u2013q22 OMIM: 613457; Cytogenetic location: 14q11\u2013q22 Genomic coordinates (GRCh38): 14:18,200,000\u2013 57,600,000 Names: Chromosome 14q11-q22 deletion syndrome {VN2}: NFKBIA168 ADCY499 GNG289 SOS275 POLE247 PNP45 SLC7A740 SLC7A839 BMP433 GZMB28 (163 more . . .) ZNF2191 WDHD11 TRD1 TEP11 RALGAPA11 PAX91 NDRG21 MIR208A1 DLGAP51 CEBPE1 BAZ1A1 AKAP61 (Implicated Genes from Microarray Studies) (Multiple incl. FLI1) \u2020\u2021 (HMGA2) \u2020\u2021 (POMP) \u2020\u2021 (RB1) \u2021 (EDNRB) \u2020\u2021 (Multiple incl. PAX9, SUPT16H, CHD8, RALGAPA1] \u2020\u2021 25 of 33 Reported Effects on Speech Dysarthric speech, absent speech [36]; impaired speech [37] Impaired speech, delayed speech, apraxia [38] Absent, impaired [38] or delayed speech [39] Delayed speech [40] Normal speech [41] Normal speech [41] Apraxia Delayed [42] or Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes (Multiple incl. PTGDR, BMP4) \u2021 14q22.1\u2013q23.1 OMIM: 609640; Cytogenetic location: 14q22.1\u2013q22.3 Genomic coordinates (GRCh38): 14:50,400,000\u2013 57,600,000 Names: Frias syndrome; Chromosome 14q22 deletion syndrome; growth de\ufb01ciency, facial anoma- lies, and brachydactyly {VN2}: GNG289 MNAT170 PRKCH35 BMP433 PSMA326 GNPNAT125 PELI224 PPM1A23 PYGL21 PTGER220 (31 more . . .) WDHD11 SIX61 SIX11 DLGAP51 14q32.2 OMIM: 608149 (paternal)/ 616222 (maternal); Cytogenetic location: 14q32 Genomic coordinates (GRCh38): 14:103,500,000\u2013107,043,718 Names: 14q32.2 Kagami\u2013Ogata syndrome; uniparental disomy, paternal, chromosome 14/14q32.2; Temple syndrome; uniparental disomy, maternal, chromosome 14 {VN2}: BDKRB232 CCNK25 BDKRB124 YY121 MIR676420 CYP46A119 PAPOLA18 DEGS213 EVL12 WARS110 (12 more . . .) MIR3451 MIR3421 MEG31 Chromosome 15 deletions 15q11.2 OMIM: 615656; Cytogenetic location: 15q11.2 Genomic coordinates (GRCh38): 15:20,500,000\u2013 25,500,000 Names: Burnside\u2013Butler syndrome; 15q11.2 BP1\u2013BP2 microdeletion {VN2}: CYFIP116 UBE3A15 TUBGCP57 SNURF7 OR4N46 SNRPN5 OR4N4C5 OR4M25 NIPA22 NIPA12 NDN2 15q11\u2013q13 OMIM: 176270 (for 5q11.2) Names: Prader-Willi syndrome; Prader-Lambhart-Willi syndrome; Labhart-Willi syndrome; Prader\u2019s syndrome; Prader-Labhart-Willi-Fanconi syndrome {VN2}: HERC222 TJP120 RYR316 GABRA516 CYFIP116 UBE3A15 GABRB315 CHRNA714 GABRG313 TUBGCP57 (20 more . . .) MTMR101 HMGN2P51 FMN11 15q11\u2013q13 OMIM: 105830 (for 15q11.2) Names: Angelman syndrome; happy puppet syndrome \u2013Same as above\u2013 15q13.3 OMIM: 612001; Cytogenetic location: 15q13.3 Genomic coordinates (GRCh38): 15:30,900,000\u2013 33,400,000 Names: Chromosome 15q13.3 microdeletion syndrome {VN2}: RYR316 CHRNA714 TRPM14 OTUD7A4 FAN14 ARHGAP11A3 MTMR101 FMN11 15q24 OMIM: 613406 Names: Witteveen\u2013Kolk syndrome; WITKOS; chromosome 15q24 deletion syndrome (included) {VN2}: CSK89 NRG482 CYP1A279 HCN456 CYP1A148 PML32 CYP11A132 SIN3A25 COX5A16 MPI15 (28 more . . .) SNX331 PTPN91 CLK31 Chromosome 16 deletions 16p11.2 OMIM: 611913; Cytogenetic location: 16p11.2 Genomic coordinates (GRCh38): 16:28,500,000\u2013 35,300,000 Names: Chromosome 16p11.2 deletion syndrome (593 kb) or 16p11.2 deletion syndrome (220 kb) {VN1} SRCAP1 {VN2}: MAPK3447 ALDOA46 CD1938 ITGAM32 VKORC131 SULT1A129 ITGAL25 STX422 PYCARD19 CDIPT19 (60 more . . .) SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 HIRIP31 AHSP1 (Implicated Genes from Microarray Studies) (DLK1, MEG3, RTL1) \u2021 (NIPA1, NIPA2, CYFIP1, TUBGCP5) \u2020\u2021 (NDN, SNRPN) \u2020\u2021 (UBE3A) \u2020\u2021 (CHRNA7, CHRFAM7A, OTUD7A) \u2020\u2021 (Multiple incl. SIN3A) \u2020\u2021 (SH2B1 \u2021, TBX6, CORO1A) \u2020\u2021 26 of 33 Reported Effects on Speech Impaired speech [43] Delayed speech; idiosyncratic speech [44] Delayed speech Delayed or Impaired speech Absent speech; impaired speech [45] Impaired or idiosyncratic speech Delayed or impaired speech Apraxia [46]; dysarthria [47]; delayed or impaired speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 16p12.2\u2013p11.2 OMIM: 613604; Cytogenetic location: 16p12.2\u2013p11.2 Genomic coordinates (GRCh38): 16:21,200,000\u201335,300,000 Names: Chromosome 16p12.2\u2013p11.2 deletion syndrome, 7.1 to 8.7 MB {VN1} SRCAP1 {VN2}: MAPK3447 PRKCB184 PLK165 ALDOA46 CD1938 SCNN1G35 SCNN1B35 TNRC6A33 ITGAM32 VKORC131 (96 more . . .) XPO61 USP311 SRCAP1 RNF401 PYDC11 ORAI31 MAZ1 IGSF61 HIRIP31 CLN31 CHP21 AHSP1 16p12.1 OMIM: 136570; Cytogenetic location: 16p12 Genomic coordinates (GRCh38): 16:24,200,000\u2013 28,500,000 Names: Chromosome 16p12.1 deletion syndrome, 520 KB {VN2}: TNRC6A33 IL4R24 CACNG320 EIF3CL14 HS3ST48 GTF3C18 SLC5A117 IL277 AQP87 NSMCE15 (7 more . . .) XPO61 CLN31 16p13.11 OMIM: 619351 Names: 16p13.1 microdeletion predisposing to autism and/or ID; megacystis\u2013microcolon\u2013 intestinal hypoperistalsis syndrome 2; MMIHS2 {VN2}: ABCC141 NDE123 MIR48423 MYH1118 RRN37 ABCC64 16p13.3 OMIM: 610543; Cytogenetic location: 16p13.3 Genomic coordinates (GRCh38): 16:0\u20137,800,000 Names: Chromosome 16p13.3 deletion syndrome, proximal; severe Rubinstein\u2013Taybi syndrome (RTS); broad thumb\u2013hallux syndrome; Rubinstein syndrome; Rubinstein\u2013Taybi deletion syndrome; RSTS deletion syndrome {VN1} CREBBP140 {VN2}: PDPK1173 CREBBP140 ADCY9102 TSC278 MLST869 GNG1368 CACNA1H60 AXIN149 UBE2I44 ELOB40 RPS235 (111 more . . .) WDR241 TFAP41 SOX81 SEPTIN121 RHBDL11 RBFOX11 PGP1 NPRL31 NAGPA1 MIR31761 HAGHL1 GNPTG1 GLIS21 FAHD11 E4F11 CHTF181 BAIAP31 16q22 OMIM: 614541; Cytogenetic location: 16q22 Genomic coordinates (GRCh38): 16:72,800,000\u2013 74,100,000 Names: Chromosome 16q22 deletion syndrome {VN1}: CMTR22 {VN2}: CDH160 TRADD50 SNTB250 SLC7A642 NFATC330 TAT29 PARD6A27 E2F426 NQO125 ST3GAL224 (83 more . . .) WWP21 PSKH11 PKD1L31 NUTF21 NOB11 CHTF81 CDH161 16q24.3\u2013q24.2 {VN2}: SLC7A548 MVD42 CYBA28 APRT28 RPL1322 CDT120 TUBB313 MC1R11 DPEP110 TRAPPC2L9 (18 more . . .) SPIRE21 CHMP1A1 Chromosome 17 deletions 17p11.2 OMIM: 182290 Names: Smith\u2013Magenis syndrome; chromosome 17p11.2 deletion syndrome {VN2}: UBB280 MAP2K3108 MAPK772 ALDH3A150 SHMT149 ALDH3A246 SREBF127 TOP3A25 MIR677820 KCNJ1217 (26 more . . .) 17p13.1 EFNB3) \u2020\u2021 OMIM: 613776; Cytogenetic location: 17p13.1 Genomic coordinates (GRCh38): 17:6,500,000\u2013 10,800,000 Names: Chromosome 17p13.1 deletion syndrome {VN1} TP53206 KDM6B8 {VN2}: TP53206 ATP1B2161 PIK3R5104 DLG476 POLR2A71 ALOX1255 ALOX15B51 ALOX12B48 DVL245 SLC2A438 VAMP237 (63 more . . .) TNK11 SHBG1 MYH41 MYH131 MYH11 MIR4971 MIR3241 DNAH21 (Implicated Genes from Microarray Studies) (Multiple incl. SH2B1) * [76] (Multiple) \u2021 (Multiple incl. MYH11) \u2020 (CREBBP, DNASE1, TRAP1) \u2020\u2021 (CBFB) \u2020\u2021 (CDH15, ZNF778, ANKRD11, ZFPM1) \u2217\u2217 (LLGL1, RAI1, UBB) \u2020\u2021 (Multiple incl. KCNAB3,"}